MedTech in Recalibration: Staying Ahead in Regulation, AI, and Operational Resilience

Sidley, ISS AG, and Swiss Medtech invite you to our annual Swiss MedTech afternoon, bringing together regulators, industry leaders, notified bodies, legal practitioners, investors, and scientific thought leaders to discuss the regulatory, technological, and commercial developments shaping the future of MedTech.

As the regulatory landscape continues to evolve, 2026 will be a defining year for Swiss and European MedTech. The MDR and IVDR revisions are progressing, the implementation timeline for the AI Act has been recalibrated under the Digital Omnibus package, and broader EU simplification initiatives are reshaping sustainability, digitalization, and reporting requirements.

At the same time, manufacturers continue to navigate geopolitical uncertainty, supply chain disruption, rising costs, and significant regulatory developments in Switzerland.

This year's programme brings together speakers from the European Commission (JRC), Swissmedic, MedTech Europe, TÜV SÜD, Medtronic, Becton Dickinson, and other key stakeholders from across the MedTech ecosystem.

Key highlights on the agenda include:

• The European Regulatory Reset: Navigating MDR/IVDR Revision and Omnibus
  The latest developments in the European regulatory framework, the Commission's simplification agenda, and what manufacturers should expect next.
• Operational Resilience in a Volatile Market Environment
  How trade policy, supply chains, sustainability, and regulatory change are influencing business strategy and manufacturing decisions.
• Switzerland: Managing New Regulatory and Compliance Challenges
  Swissmedic supervisory fees, swissdamed, the proposed TPITO revision, and evolving compliance expectations for manufacturers operating in Switzerland.
• AI in Medical Devices: From Regulation to Implementation
  The revised timeline for AI-enabled medical devices and the practical implications for MDSW strategy, data governance, and compliance planning. 

Who should attend?

Executives, investors, in-house counsel, and regulatory managers interested in and/or facing regulatory issues in Switzerland.

For more information or questions, please contact Geneva Events.